Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Piperacillin Sodium and Tazobactam Sodium for Injection(4:1)

Approval Number

国药准字H20110066

Company海南通用三洋药业有限公司

Registration Date

March 22, 2021

Drug Information

Generic Name

注射用哌拉西林钠他唑巴坦钠(4:1)

Brand Name

玻特利

Dosage Form

注射剂

Strength

2.5g (C23H27N5O7S 2.0g与C10H12N4O5S 0.5g)

Drug Type

化学药品

Registration Date

March 22, 2021

Company Information

Applicant Company

Company Name海南通用三洋药业有限公司

Manufacturing Company

Company Name海南通用三洋药业有限公司

Company Address

海口市秀英区海力路8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用哌拉西林钠他唑巴坦钠(4:1) - NMPA 批准文号 | MedPath